BIO Deutschland Member Directory

Regensburg, Germany

2bind is a contract research organization in the field of biophysical analysis. The company's clients and collaborators mainly work in drug discovery (hit identification, hit validation, and hit characterization), aptamer generation, antibody development, and protein biochemistry. The company's mission is to support and help their partners with their innovative biophysical services to drive their science.

3B Pharmaceuticals GmbH

Berlin, Germany

3B Pharmaceuticals GmbH (3BP) is a biotechnology company developing targeted radiopharmaceutical drugs and diagnostics for oncology indications with a high unmet medical need. The company is active in peptide discovery and optimization and has built a technology platform extending from hit identification to early clinical development. Technologies are applied to both in-house and collaborative R&D.

4GENE GmbH

Freising, Germany

4GENE GmbH develops and produces natural, biotechnologically engineered, activatable flavor and fragrance precursors. The company's products are marketed as FLAVOR-ON-DEMAND. The company has developed a biotechnical platform technology that allows the identification and application of biocatalysts for the glucosylation of small molecules.

4SC AG

Planegg-Martinsried, Germany

4SC AG is a clinical-stage biopharmaceutical company. The company is engaged in developing small-molecule drugs that can target key indications in cancer with unmet medical needs through epigenetic mechanisms. The company's current product pipeline includes two programs in clinical development: resminostat and domatinostat.

AATec Medical GmbH

Munich, Germany

AATec Medical GmbH is involved in research and development in the field of natural sciences, engineering, agricultural sciences and medicine The company is also involved in the development, clinical testing, production and approval-compliant marketing of drugs based on innovative biotechnology.

AB Enzymes GmbH

Darmstadt, Germany

AB Enzymes develops and distributes enzymes. The products range from food enzymes for baking and beverages to enzymes for animal feed, textile technology and the detergents industry. AB Enzymes’ focus in the biofuel market is in the use of lignocellulosic biomass to produce transport fuels.

Abalos Therapeutics GmbH

Düsseldorf, Germany

Abalos Therapeutics develop a novel anti-cancer approach that provides the full breadth of the immune system’s power specifically against cancer cells. Abalos’ arenavirus-based drug candidates are designed to awake precise immune responses and activate all relevant immune cell types against primary tumors and metastases.

AbbVie Germany GmbH & Co. KG

Wiesbaden, Germany

AbbVie Deutschland GmbH & Co. KG is a global, research-based biopharmaceutical company. The company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases.

Acaryon GmbH

Berlin, Germany

Acaryon GmbH is a company specialized in the development of specific and innovative natural microorganisms for probiotic and microbiome applications for the pharmaceutical and food industry. Moreover, Acaryon provides analytical services for a different range of purposes.

acCELLerate GmbH

Hamburg, Germany

acCELLerate GmbH develops cell based assay kits for applications in research, safety, quality control and diagnostics. The company's instaCELL bioassays are based on ready made cryopreserved cells which can be directly used in an assay without prior cultivation or even cell counting. The kits contain all required components, assay plates, medium, reagents, controls and cells.

Acousia Therapeutics GmbH

Tübingen, Germany

Acousia is developing a series of small molecule drug candidates for local and systemic treatment of different forms of hearing loss. The company's lead product ACOU085 is a proprietary, small-molecule otoprotective drug candidate, which is currently being tested in a Phase 1b clinical trial involving age-related hearing loss (ARHL) patients.

acromion GmbH

Frechen, Germany

acromion GmbH is a Contract Research Organization (CRO) with experience in medical and bioscientific research. The company provide full-service in trial organization and conduct, clinical monitoring, clinical data management, statistics, quality assurance and medical writing for phase I to IV clinical and non-interventional (NIS) trials

adivo GmbH

Bayern, Germany

Adivo GmbH, a German biotech company specializing in generating species-specific therapeutic antibodies for companion animals. The company develops new technologies to expand the range of therapeutic options for pet cancer and chronic inflammatory conditions.

Adrenomed AG

Hennigsdorf, Germany

Adrenomed AG is a clinical-stage biopharmaceutical company. The company's mission is to rescue vascular integrity in order to save the lives of critically ill patients with limited treatment options. The company's lead product candidate Adrecizumab (INN: enibarcimab) is a non-blocking monoclonal antibody. Adrecizumab targets the vasoprotective peptide Adrenomedullin, an essential regulator of vascular integrity.

Aeterna Zentaris GmbH

Frankfurt, Germany

Aeterna Zentaris is a specialty biopharmaceutical company engaged in developing and commercializing novel treatments in oncology, endocrinology and women's health. The development and research site is based in Germany.

Affimed N.V

Heidelberg, Germany

Affimed (Nasdaq: AFMD) is a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer by actualizing the untapped potential of the innate immune system. The company’s proprietary ROCK® platform enables a tumor-targeted approach to recognize and kill a range of hematologic and solid tumors, enabling a broad pipeline of wholly-owned and partnered single agent and combination therapy programs. The ROCK® platform predictably generates customized...

AGC Biologics – Heidelberg

Heidelberg, Germany

AGC Biologics is a global contract development and manufacturing organization (CDMO), dedicated to the development and manufacture of biopharmaceuticals, from pre-clinical to commercial. The company offers deep industry expertise and uniquely customized services for the scale-up and cGMP manufacture of protein-based therapeutics, from pre-clinical to commercial production, using mammalian and microbial production systems.

AiCuris Anti-infective Cures AG

Wuppertal, Germany

AiCuris is a pharmaceutical company focused on the discovery, research and development of antiviral and antibacterial agents for the treatment of severe and potentially life-threatening infectious diseases.The company’s first product, Letermovir (Prevymis®) is a therapy for human cytomegalovirus (HCMV) infections.

AIT Austrian Institute of Technology GmbH

Vienna, Austria

AIT Austrian Institute of Technology GmbH is a non-university research institution and the Molecular Diagnostics business unit within the Health & Environment Department. AIT provides research and technological development to understand the basic innovations for the next generation of infrastructure related technologies in the fields of energy, mobility systems, low-emission transport, health & bioresources, digital safety & security, vision, automation & control and technology experience.

akampion

Berlin, Germany

akampion provides full-service public relations, investor relations and marketing communications to healthcare and technology companies. The company's services include Reputation management, strategic advice, integrated corporate communications, storytelling, public relations, investor relations, product PR, perception studies, marketing, online PR, media training and employee branding.